| <
Supplementary treatments
Hayden McRobbie
Abstract
UK stop smoking services typically aim to provide evidence-based
treatments that combine multi-session behavioural support
with nicotine replacement treatments or bupropion. Service
providers are under pressure to achieve not only a large
throughput of smokers but high short-term abstinence rates.
Some supplementary treatments such as glucose might be
helpful to smokers trying to quit and can be incorporated
into clinical practice. Others (e.g. exercise, aversive
smoking) show some promise, but further evidence of their
effectiveness and the practicality of their implementation
is required.
Clients of NHS services may enquire about the use of acupuncture
and hypnosis and, despite the lack of evidence that these
are effective in aiding cessation, many health professionals
still recommend them. Finally this presentation will briefly
discuss some of the non-tested products and methods of
stopping smoking that are available to the smoker.
Biography
Hayden McRobbie is a Research Fellow at the Tobacco Dependence
Research Centre at Barts and The London School of Medicine,
University of London. After graduating from the University
of Otago, New Zealand in 1996, he worked in a general
medicine and surgery before taking up his current post
working with Professor Peter Hajek in 1999. He is also
a clinician at the Royal London Hospital Smokers' Clinic,
one of the largest in the UK.
Hayden is currently studying for a PhD looking alleviation
of the tobacco withdrawal syndrome.
Hayden McRobbie
Research Fellow,
Tobacco Dependence Research and Treatment Centre,
Barts and The London School of Medicine,
University of London
| 
